In addition, although sNGAL increased under cisplatin stimulation, it seems to be protective for cisplatin-induced AKI because Devarajan et al. reported administration of biologically active recombinant NGAL via the tail vein could significantly ameliorate impaired renal function in cisplatin-induced AKI [24]. This evidence concerns the gene LCN2 and acute kidney injury.